These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35749302)

  • 21. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
    Mimae T; Tsuta K; Kondo T; Nitta H; Grogan TM; Okada M; Asamura H; Tsuda H
    Ann Oncol; 2012 Dec; 23(12):3129-3137. PubMed ID: 22700994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent genetic aberrations in thymoma and thymic carcinoma.
    Zettl A; Ströbel P; Wagner K; Katzenberger T; Ott G; Rosenwald A; Peters K; Krein A; Semik M; Müller-Hermelink HK; Marx A
    Am J Pathol; 2000 Jul; 157(1):257-66. PubMed ID: 10880395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
    Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
    PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic epithelial tumor medical treatment: A narrative review.
    Huang Q; Zhu L; Liu Y; Zhang Y
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189167. PubMed ID: 39117091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
    Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
    Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
    Elm L; Levidou G
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy-relevant mutations of receptor tyrosine kinases in malignant thymomas and thymic carcinomas: a therapeutic perspective].
    Ströbel P; Knop S; Einsele H; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 2007; 91():177-86. PubMed ID: 18314613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
    Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J
    Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of p16
    Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
    J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic insights into molecular profiling of thymic carcinoma: a narrative review.
    Takata S
    Mediastinum; 2024; 8():39. PubMed ID: 39161584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational landscape of thymic epithelial tumors in a Chinese population: insights into potential clinical implications.
    Wang H; Xu X; Luo L; Wang C; Jiang Z; Lin Y
    Gland Surg; 2021 Apr; 10(4):1410-1417. PubMed ID: 33968692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
    Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
    Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular aspects of thymic carcinoma.
    Weissferdt A; Wistuba II; Moran CA
    Lung Cancer; 2012 Nov; 78(2):127-32. PubMed ID: 22921473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
    Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
    Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
    Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
    Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies.
    Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM
    Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.